Clinical Trial News Archive - February 2023
February 1, 2023
- Beactica Therapeutics Receives FDA Orphan Drug Designation for BEA-17 for the Treatment of Glioblastoma
- Ionis Announces GSK Has Advanced Bepirovirsen Into Phase 3 Development
- Ionis announces GSK has advanced bepirovirsen into Phase 3 development
February 2, 2023
February 6, 2023
- Results in Phase 2 scleroderma study by Certa Therapeutics demonstrates improvement in more than 60% of patients
- Genentech Announces Positive Data From Global Phase III Program for Crovalimab in PNH, a Rare, Life-Threatening Blood Condition
- Janssen Reports Positive Topline Phase 2 Results for Nipocalimab in Pregnant Individuals at High Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
February 7, 2023
February 8, 2023
February 9, 2023
February 10, 2023
February 13, 2023
- Tascenso ODT (fingolimod) Launched to Meet the Needs of Multiple Sclerosis Patients in the US Left Without Essential Patient Support
- Pharmazz, Inc. Announces US FDA Clearance for a Phase III Clinical Trial of Sovateltide (PMZ-1620) in Acute Cerebral Ischemic Stroke Patients
February 14, 2023
February 15, 2023
- Sera Prognostics Announces Positive Top-line Data from AVERT PRETERM TRIAL
- NIH Trial to Evaluate Shionogi Antiviral in Adults Hospitalized with COVID-19
- Coherus and Junshi Biosciences Announce Positive Final Overall Survival Results of JUPITER-02, a Phase 3 Clinical Trial Evaluating Toripalimab as Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma
- Landmark New England Journal of Medicine Publication Reinforces Potential of GSK’s Respiratory Syncytial Virus Older Adult Vaccine Candidate
February 16, 2023
- INOVIO Announces Positive Preliminary Results from Second Cohort of Phase 1/2 Trial with INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis
- Trial Data Indicates Targeted, Short Course Radiation Therapy Preserves Urinary Continence and Sexual Function Better Than Surgery in Men With Prostate Cancer
- Aldeyra Therapeutics Advances Investigational Oral RASP Modulator ADX‑629 Into New Phase 2 Systemic Disease Trials
- Pfizer Announces The Lancet Neurology Has Published Phase 3 Data for Zavegepant for the Acute Treatment of Migraine in Adults
February 17, 2023
February 20, 2023
February 21, 2023
- ObvioHealth Announces Digital Therapeutics API to Capture More Accurate Efficacy and Adherence Data in Clinical Trials
- U.S. FDA Accepts Biologics License Application for Pfizer’s Respiratory Syncytial Virus Maternal Vaccine Candidate for Priority Review
- ReSViNet 2023 Data Reinforce AstraZeneca’s Commitment to Help Prevent Respiratory Syncytial Virus in Infants
February 22, 2023
- Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, in Combination With Keytruda (pembrolizumab), was Granted Breakthrough Therapy Designation by the FDA for Adjuvant Treatment of Patients With High-Risk Melanoma Following Complete Resection
- ADHD Medication AZSTARYS Shown Safe and Effective in Long-Term Study
- Astellas Announces Update on Preliminary Safety and Efficacy Data from FORTIS Study of Investigational AT845 in Adults with Late-Onset Pompe Disease
February 23, 2023
February 24, 2023
February 26, 2023
February 27, 2023
February 28, 2023
Clinical trial results archive
- 2024
- January, February, March, April, May
- 2023
- January, February, March, April, May, June, July, August, September, October, November, December
- 2022
- January, February, March, April, May, June, July, August, September, October, November, December
- 2021
- January, February, March, April, May, June, July, August, September, October, November, December
- 2020
- January, February, March, April, May, June, July, August, September, October, November, December
- 2019
- January, February, March, April, May, June, July, August, September, October, November, December
- 2018
- January, February, March, April, May, June, July, August, September, October, November, December
- 2017
- May, June, July, August, September, October, November, December
- 2016
- October
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.